Pelago Announces $58M Series C Funding
Summary
Pelago, the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced $58 million in new funding on the strength of customer growth and validated ROI, bringing total funding to $151 million. As part of this latest round, Atomico Partner Laura Connell will join the Pelago board. Pelago partners with enterprises as the leading virtual clinic for substance use management among their employees. Pelagos cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible and effective support that seamlessly integrates with health plans, pharmacy benefit managers and wellness platforms. Tens of thousands of members enroll in the Pelago program each year, and more than 3.4 million now have access to the digital clinic.
Funding
Review available funding amount, funding date, investors, and linked company information related to Pelago Announces $58M Series C Funding in the interactive ISVWorld profile.